[vc_row][vc_column width=”1/1″][ultimate_heading main_heading=”“A Conversation with the Experts”” heading_tag=”h2″ alignment=”center” spacer=”line_only” spacer_position=”top” spacer_img_width=”48″ line_style=”solid” line_height=”1″ line_color=”#333333″ icon_type=”selector” icon_size=”32″ icon_style=”none” icon_color_border=”#333333″ icon_border_size=”1″ icon_border_radius=”500″ icon_border_spacing=”50″ img_width=”48″ line_icon_fixer=”10″ main_heading_font_family=”font_family:Oswald|font_call:Oswald” main_heading_style=”font-weight:bold;” sub_heading_font_family=”font_family:Oswald|font_call:Oswald|variant:300″ sub_heading_style=”font-weight:300;” main_heading_color=”#000000″ main_heading_margin=”margin-bottom:20px;”]
Should Marijuana be moved from Schedule 1 to Schedule 2?
[gap size=”40px”] On Friday, October 24, 2014, Dr. Carl Hart, author of High Price, participated in a panel discussion about the consequences of legalizing medical marijuana.
[gap size=”40px”]
What You should Know:
[gap size=”40px”]The real reason why American Scientists ignore the benefits of drugs [gap size=”40px”]
Four states and Washington, D.C., allow recreational marijuana. Nineteen states allow it for medical purposes, and 14 have decriminalized it. [gap size=”40px”]
[/ultimate_heading][text_output]
[/text_output][ultimate_heading heading_tag=”h2″ alignment=”left” spacer=”no_spacer” spacer_position=”top” spacer_img_width=”48″ line_style=”solid” line_height=”1″ line_color=”#333333″ icon_type=”selector” icon_size=”32″ icon_style=”none” icon_color_border=”#333333″ icon_border_size=”1″ icon_border_radius=”500″ icon_border_spacing=”50″ img_width=”48″ line_icon_fixer=”10″ main_heading_font_family=”font_family:Oswald|font_call:Oswald” main_heading_style=”font-weight:bold;” main_heading_font_size=”40″ sub_heading_font_family=”font_family:Oswald|font_call:Oswald|variant:300″ sub_heading_style=”font-weight:300;” sub_heading_font_size=”25″]Also on the legalize medical marijuana panel were:
- David Blake, deputy attorney general for legal policy and government affairs of Colorado
- Beau Kilmer, senior policy researcher at the RAND Corporation
- Bertha K. Madras, Harvard University professor and chair of Harvard’s Division of Neurochemistry
- Robert Mikos, Vanderbilt law professor and a leading expert on federalism and drug law
- Scott Teitelbaum, University of Florida College of Medicine psychiatry and pediatrics professor and vice chair of the Psychiatry Department
[/ultimate_heading][/vc_column][/vc_row]